SignatureFD’s Supernus Pharmaceuticals SUPN Stock Holding History

SignatureFD’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.5K	Sell	527 -251	-32%	-$12.1K	﹤0.01%	2245
2026 Q1	$40.2K	Buy	778 +105	+16%	+$5.35K	﹤0.01%	1857
2025 Q4	$33.4K	Buy	673 +114	+20%	+$5.54K	﹤0.01%	1874
2025 Q3	$26.7K	Buy	559 +28	+5%	+$1.13K	﹤0.01%	1974
2025 Q2	$16.7K	Buy	531 +8	+2%	+$256	﹤0.01%	2137
2025 Q1	$17.1K	Sell	523 -38	-7%	-$1.35K	﹤0.01%	2137
2024 Q4	$20.3K	Hold	561	–	–	﹤0.01%	2056
2024 Q3	$17.5K	Hold	561	–	–	﹤0.01%	2103
2024 Q2	$15K	Sell	561 -96	-15%	-$2.78K	﹤0.01%	2096
2024 Q1	$22.4K	Sell	657 -7	-1%	-$208	﹤0.01%	1947
2023 Q4	$19.2K	Buy	664 +221	+50%	+$5.86K	﹤0.01%	1948
2023 Q3	$12.2K	Buy	443 +22	+5%	+$670	﹤0.01%	2099
2023 Q2	$12.7K	Sell	421 -32	-7%	-$1.12K	﹤0.01%	2134
2023 Q1	$16.4K	Sell	453 -2	-0.4%	-$77	﹤0.01%	1974
2022 Q4	$16.2K	Hold	455	–	–	﹤0.01%	1911
2022 Q3	$15K	Buy	455 +160	+54%	+$5.21K	﹤0.01%	1889
2022 Q2	$9K	Buy	295 +4	+1%	+$115	﹤0.01%	2190
2022 Q1	$9K	Hold	291	–	–	﹤0.01%	2222
2021 Q4	$8K	Hold	291	–	–	﹤0.01%	2232
2021 Q3	$8K	Hold	291	–	–	﹤0.01%	2191
2021 Q2	$9K	Hold	291	–	–	﹤0.01%	2053
2021 Q1	$8K	Hold	291	–	–	﹤0.01%	1969
2020 Q4	$7K	Sell	291 -34	-10%	-$732	﹤0.01%	1858
2020 Q3	$7K	Buy	325 +198	+156%	+$4.49K	﹤0.01%	1789
2020 Q2	$3K	Buy	+127	New	+$2.81K	﹤0.01%	2018
2020 Q1	–	Sell	-19	Closed	–	–	2440
2019 Q4	$0	Hold	19	–	–	﹤0.01%	2266
2019 Q3	$1K	Hold	19	–	–	﹤0.01%	2015
2019 Q2	$1K	Hold	19	–	–	﹤0.01%	1947
2019 Q1	$1K	Hold	19	–	–	﹤0.01%	1902
2018 Q4	$1K	Hold	19	–	–	﹤0.01%	1864
2018 Q3	$1K	Hold	19	–	–	﹤0.01%	1836
2018 Q2	$1K	Hold	19	–	–	﹤0.01%	1852
2018 Q1	$1K	Buy	+19	New	+$793	﹤0.01%	1686

Other funds holding SUPN

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

CNAM

Campbell Newman Asset Management Milwaukee, Wisconsin $1.35B AUM 38.87% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

SignatureFD's SUPN Position: Q2 2026 in Review

SignatureFD reduced its Supernus Pharmaceuticals (SUPN) stake by 32% in Q2 2026, selling an estimated $12.1K and leaving 527 shares worth $24.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2245.

SignatureFD first reported a position in SUPN in Q1 2018 and has held it in 33 quarters since. The position peaked at $40.2K in Q1 2026. 51 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

SignatureFD held 527 shares of Supernus Pharmaceuticals worth $24.5K as of Q2 2026.
SignatureFD sold 251 Supernus Pharmaceuticals shares in Q2 2026, an estimated $12.1K.
Supernus Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2245 holding.
SignatureFD first reported a position in Supernus Pharmaceuticals in Q1 2018 and has held it in 33 quarters since.
SignatureFD's Supernus Pharmaceuticals position peaked at $40.2K in Q1 2026.
51 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.